Westlake Chemical Partners LP cash flow to debt ratio of 70.17% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Westlake Chemical Partners LP's free cash flow has decreased 53.75% from $436.03M last year to $201.65M, signaling decreasing performance

Westlake Chemical Partners LP's debt to equity ratio is 1.58, which means that the company's assets are unhealthy financed, signaling financial risk.

Westlake Chemical Partners LP's debt has increased relative to shareholder equity from 0.77 last year to 1.58 today, signaling weakened financials

Westlake Chemical Partners LP has a net debt to EBITDA ratio of 0.79x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Westlake Chemical Partners LP's interest coverage ratio of 10.34 indicates that earnings with good margin can cover interest payments on company debt

Westlake Chemical Partners LP's profit margin has decreased (15.07%) in the last year from 5.49% to 4.66%, signaling decreasing performance

Westlake Chemical Partners LP's short-term assets of $143.51M exceed its short-term liabilities of $51.30M

Westlake Chemical Partners LP's return on assets of 4.73% is lower than the 5.00% threshold, indicating inefficient asset utilization

Westlake Chemical Partners LP's return on equity of 13.12%, is lower than 15.00%, indicating bad performance

Westlake Chemical Partners LP's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Westlake Chemical Partners LP had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Westlake Chemical Partners LP has positive free cash flow, indicating the company generates cash after capital expenditures

Westlake Chemical Partners LP has a free cash flow yield of 26.39%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Westlake Chemical Partners LP's yearly earnings has decreased 21.95% since last year from $62.39M to $48.70M, signaling decreasing performance

Westlake Chemical Partners LP's yearly revenue has increased 2.71% since last year from $1.14B to $1.17B, signaling increasing performance

ROIC 30.30% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Westlake Chemical Partners LP's 3-year revenue CAGR of -9.86% is negative, indicating declining revenue over the past 3 years

Westlake Chemical Partners LP had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Westlake Chemical Partners LP had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Westlake Chemical Partners LP is undervalued relative to its fair value price of 33.50 based on Discounted Cash Flow model

Westlake Chemical Partners LP has an earnings yield of 7.46%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Westlake Chemical Partners LP is undervalued relative to its fair value price of 79.29 based on EBITDA multiple model

Westlake Chemical Partners LP has an EV/EBITDA ratio of 2.49x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Westlake Chemical Partners LP is undervalued relative to its fair value price of 111.72 based on Earnings Fair Value model

Westlake Chemical Partners LP's earnings growth over the measurement period is negative; the PEG ratio is not meaningful and the check fails.

Westlake Chemical Partners LP has a price-to-book ratio of 1.00x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Westlake Chemical Partners LP has a price-to-sales ratio of 0.62x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue